Dysphagia Evaluation After Stroke- Effect Oral Neuromuscular Training on Swallowing Dysfunction
Launched by UMEÅ UNIVERSITY · Nov 7, 2016
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how a special rehabilitation program, which uses an oral device, can help improve swallowing difficulties (called dysphagia) in people who have had a stroke. Many stroke patients struggle with swallowing long after their stroke, and this study aims to see if this specific training can make a difference for them.
To participate in the trial, patients need to be between 65 and 74 years old and must still have swallowing issues at least 12 weeks after their first stroke. However, those with other serious health problems that affect swallowing or their ability to participate won't be included. If eligible, participants can expect to engage in targeted exercises using the oral device to help strengthen their swallowing muscles. The study is currently recruiting, and it's a chance to contribute to research that could improve recovery for many stroke survivors facing swallowing challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Persistent dysphagia 12(±3) weeks after STROKE.
- Exclusion Criteria:
- • Stroke patients with neurologic or psychiatric disorders or other diseases/conditions that can affect swallowing function.
- • Unable to collaborate due to other serious diseases and/or to affected general condition.
About Umeå University
Umeå University, a leading research institution in Sweden, is dedicated to advancing healthcare through innovative clinical trials and translational research. With a strong emphasis on interdisciplinary collaboration, the university harnesses cutting-edge technology and expert knowledge across various fields to address critical health challenges. Its commitment to ethical standards and patient safety ensures that all clinical trials conducted under its auspices are designed to generate robust scientific evidence, ultimately contributing to improved health outcomes and informed medical practices. Umeå University strives to foster a dynamic research environment that supports the development of new therapies and enhances the understanding of complex health issues.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Umeå, , Sweden
Patients applied
Trial Officials
Patricia Hägglund, PhD/SLP
Principal Investigator
Umeå University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials